Histogenics Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8.00
-
-
-
-
450
Cost of Goods Sold (COGS) incl. D&A
566.00
726.00
1,614.00
1,673.00
1,534.00
450
Gross Income
558.00
726.00
1,614.00
1,673.00
1,534.00
450
SG&A Expense
16,227.00
31,876.00
29,895.00
28,434.00
23,416.00
25,388
EBIT
16,785.00
32,602.00
31,509.00
30,107.00
24,950.00
25,838
Unusual Expense
8,875.00
9,947.00
310.00
17,307.00
1,482.00
17,871
Non Operating Income/Expense
52.00
13.00
72.00
248.00
116.00
839
Interest Expense
-
151.00
133.00
3,160.00
-
-
Pretax Income
25,712.00
22,793.00
32,024.00
16,208.00
26,414.00
8,643
Consolidated Net Income
56,003.00
10,510.00
32,024.00
16,208.00
26,414.00
8,643
Net Income
56,003.00
10,510.00
32,024.00
16,208.00
26,414.00
8,643
Net Income After Extraordinaries
56,003.00
10,510.00
32,024.00
16,208.00
26,414.00
8,643
Net Income Available to Common
56,003.00
10,510.00
32,024.00
13,863.00
22,499.00
8,522
EPS (Basic)
4.10
6.85
2.42
2.18
0.99
0.79
Basic Shares Outstanding
13,643.20
1,534.10
13,231.10
14,257.00
22,669.80
36,398.50
EPS (Diluted)
4.10
6.85
2.42
2.18
0.99
0.79
Diluted Shares Outstanding
13,643.20
1,534.10
13,231.10
14,389.20
22,669.80
37,090.20
EBITDA
16,219.00
31,876.00
29,895.00
28,434.00
23,416.00
25,388
Non-Operating Interest Income
-
-
-
-
134.00
163
Other After Tax Income (Expense)
30,291.00
12,283.00
-
-
-
-
Preferred Dividends
-
-
-
2,345.00
3,915.00
121
About Histogenics
View Profile
